Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001192482-20-000736

Options or other derivatives

  • President and CEO acquired 411,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BEN-MAIMON CAROLE · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-09-29 Grant or award : show line 1 in the form Stock Option (right to buy) +411,400 411,400 D
Loading xslF345X03/edgar.xml…